Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T22:41:59.586Z.
Calculation as of: 2026-10-06T22:41:59.586Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 758569c9a5200ff865148ece812cfee1584848efe17be54014067a65be913c54
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2023-09-29.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
10.02x
EV/EBIT RATIO AVG 3Y
18.68x
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$62.78M
EV/EBIT Ratio
N/A
TTM Avg
237.48x
3Y Avg
237.48x
5Y Avg
237.48x
Market Cap
$63.78M
EV/EBIT Ratio
N/A
TTM Avg
31.50x
3Y Avg
31.50x
5Y Avg
31.50x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InterCure Ltd. (INCR) | $63.02M | N/A | 10.02x | 18.68x | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | N/A | 237.48x | 237.48x | 237.48x |
| RenovoRx, Inc. (RNXT)vs › | $62.62M | N/A | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | N/A | 31.50x | 31.50x | 31.50x |
| Alps Group Inc (ALPS)vs › | $64.18M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | N/A | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $65.85M | N/A | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $65.86M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | N/A | N/A | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2023-09-29 | 12.32x |
| 2023-09-28 | 12.13x |
| 2023-09-27 | 12.25x |
| 2023-09-26 | 12.06x |
| 2023-09-25 | 12.51x |
| 2023-09-22 | 12.69x |
| 2023-09-21 | 12.76x |
| 2023-09-20 | 12.82x |
| 2023-09-19 | 12.95x |
| 2023-09-18 | 13.14x |
| 2023-09-15 | 13.07x |
| 2023-09-14 | 13.26x |
| 2023-09-13 | 12.76x |
| 2023-09-12 | 12.13x |
| 2023-09-11 | 13.14x |
| 2023-09-08 | 13.01x |
| 2023-09-07 | 12.63x |
| 2023-09-06 | 13.26x |
| 2023-09-05 | 12.88x |
| 2023-09-01 | 12.25x |
| 2023-08-31 | 9.05x |
| 2023-08-30 | 8.64x |
| 2023-08-29 | 8.14x |
| 2023-08-28 | 8.51x |
| 2023-08-25 | 8.60x |
| 2023-08-24 | 8.51x |
| 2023-08-23 | 8.80x |
| 2023-08-22 | 8.76x |
| 2023-08-21 | 8.80x |
| 2023-08-18 | 8.27x |
| 2023-08-17 | 8.80x |
| 2023-08-16 | 8.80x |
| 2023-08-15 | 8.72x |
| 2023-08-14 | 8.80x |
| 2023-08-11 | 8.60x |
| 2023-08-10 | 8.60x |
| 2023-08-09 | 8.93x |
| 2023-08-08 | 9.26x |
| 2023-08-07 | 8.76x |
| 2023-08-04 | 8.76x |
| 2023-08-03 | 8.93x |
| 2023-08-02 | 8.93x |
| 2023-08-01 | 8.93x |
| 2023-07-31 | 8.97x |
| 2023-07-28 | 8.97x |
| 2023-07-27 | 8.97x |
| 2023-07-26 | 9.01x |
| 2023-07-25 | 8.93x |
| 2023-07-24 | 8.93x |
| 2023-07-21 | 9.22x |
| 2023-07-20 | 9.22x |
| 2023-07-19 | 9.34x |
| 2023-07-18 | 9.30x |
| 2023-07-17 | 8.97x |
| 2023-07-14 | 9.18x |
| 2023-07-13 | 9.30x |
| 2023-07-12 | 9.43x |
| 2023-07-11 | 9.51x |
| 2023-07-10 | 9.38x |
| 2023-07-07 | 8.89x |
| 2023-07-06 | 9.18x |
| 2023-07-05 | 8.89x |
| 2023-07-03 | 9.43x |
| 2023-06-30 | 9.43x |
| 2023-06-29 | 9.51x |
| 2023-06-28 | 9.88x |
| 2023-06-27 | 9.84x |
| 2023-06-26 | 10.01x |
| 2023-06-23 | 10.34x |
| 2023-06-22 | 10.63x |
| 2023-06-21 | 10.54x |
| 2023-06-20 | 10.67x |
| 2023-06-16 | 11.21x |
| 2023-06-15 | 11.21x |
| 2023-06-14 | 11.04x |
| 2023-06-13 | 11.58x |
| 2023-06-12 | 10.96x |
| 2023-06-09 | 11.50x |
| 2023-06-08 | 11.25x |
| 2023-06-07 | 10.88x |
| 2023-06-06 | 10.67x |
| 2023-06-05 | 10.25x |
| 2023-06-02 | 10.38x |
| 2023-06-01 | 10.30x |
| 2023-05-31 | 10.42x |
| 2023-05-30 | 10.42x |
| 2023-05-26 | 11.04x |
| 2023-05-25 | 10.88x |
| 2023-05-24 | 11.21x |
| 2023-05-23 | 11.62x |
| 2023-05-22 | 11.99x |
| 2023-05-19 | 12.12x |
| 2023-05-18 | 12.20x |
| 2023-05-17 | 12.12x |
| 2023-05-16 | 12.32x |
| 2023-05-15 | 13.07x |
| 2023-05-12 | 12.74x |
| 2023-05-11 | 13.11x |
| 2023-05-10 | 12.45x |
| 2023-05-09 | 12.24x |
| 2023-05-08 | 12.24x |
| 2023-05-05 | 11.79x |
| 2023-05-04 | 11.25x |
| 2023-05-03 | 11.37x |
| 2023-05-02 | 11.33x |
| 2023-03-31 | 4.70x |
| 2023-03-30 | 4.75x |
| 2023-03-29 | 4.75x |
| 2023-03-28 | 4.90x |
| 2023-03-27 | 4.85x |
| 2023-03-24 | 4.85x |
| 2023-03-23 | 4.99x |
| 2023-03-22 | 4.75x |
| 2023-03-21 | 4.44x |
| 2023-03-20 | 4.15x |
| 2023-03-17 | 4.17x |
| 2023-03-16 | 4.29x |
| 2023-03-15 | 4.44x |
| 2023-03-14 | 4.56x |
| 2023-03-13 | 4.58x |
| 2023-03-10 | 4.51x |
| 2023-03-09 | 4.85x |
| 2023-03-08 | 5.19x |
| 2023-03-07 | 5.31x |
| 2023-03-06 | 5.52x |
| 2023-03-03 | 5.88x |
| 2023-03-02 | 5.88x |
| 2023-03-01 | 5.81x |
| 2023-02-28 | 5.74x |
| 2023-02-27 | 6.10x |
| 2023-02-24 | 6.41x |
| 2023-02-23 | 6.56x |
| 2023-02-22 | 6.53x |
| 2023-02-21 | 6.46x |
| 2023-02-17 | 7.45x |
| 2023-02-16 | 7.47x |
| 2023-02-15 | 7.98x |
| 2023-02-14 | 8.10x |
| 2023-02-13 | 7.96x |
| 2023-02-10 | 8.46x |
| 2023-02-09 | 8.85x |
| 2023-02-08 | 8.89x |
| 2023-02-07 | 8.82x |
| 2023-02-06 | 8.77x |
| 2023-02-03 | 8.73x |
| 2023-02-02 | 9.35x |
| 2023-02-01 | 8.75x |
| 2023-01-31 | 8.65x |
| 2023-01-30 | 8.46x |
| 2023-01-27 | 8.82x |
| 2023-01-26 | 8.80x |
| 2023-01-25 | 8.70x |
| 2023-01-24 | 8.77x |
| 2023-01-23 | 8.65x |
| 2023-01-20 | 9.06x |
| 2023-01-19 | 9.09x |
| 2023-01-18 | 8.70x |
| 2023-01-17 | 8.68x |
| 2023-01-13 | 8.97x |
| 2023-01-12 | 9.21x |
| 2023-01-11 | 8.68x |
| 2023-01-10 | 8.87x |
| 2023-01-09 | 9.42x |
| 2023-01-06 | 8.94x |
| 2023-01-05 | 9.02x |
| 2023-01-04 | 8.61x |
| 2023-01-03 | 8.34x |
| 2022-12-30 | 7.74x |
| 2022-12-29 | 8.08x |
| 2022-12-28 | 7.67x |
| 2022-12-27 | 8.08x |
| 2022-12-23 | 9.02x |
| 2022-12-22 | 9.06x |
| 2022-12-21 | 9.59x |
| 2022-12-20 | 9.59x |
| 2022-12-19 | 9.91x |
| 2022-12-16 | 10.24x |
| 2022-12-15 | 10.10x |
| 2022-12-14 | 10.27x |
| 2022-12-13 | 10.85x |
| 2022-12-12 | 10.48x |
| 2022-12-09 | 10.63x |
| 2022-12-08 | 11.04x |
| 2022-12-07 | 11.13x |
| 2022-12-06 | 10.99x |
| 2022-12-05 | 11.50x |
| 2022-12-02 | 11.57x |
| 2022-12-01 | 11.50x |
| 2022-11-30 | 11.74x |
| 2022-11-29 | 11.11x |
| 2022-11-28 | 11.23x |
| 2022-11-25 | 11.86x |
| 2022-11-23 | 11.45x |
| 2022-11-22 | 11.98x |
| 2022-11-21 | 11.28x |
| 2022-11-18 | 11.83x |
| 2022-11-17 | 11.62x |
| 2022-11-16 | 12.31x |
| 2022-11-15 | 12.46x |
| 2022-11-14 | 13.04x |
| 2022-11-11 | 12.07x |
| 2022-11-10 | 11.78x |
| 2022-11-09 | 11.23x |
| 2022-11-08 | 11.69x |
| 2022-11-07 | 11.57x |
| 2022-11-04 | 11.35x |
| 2022-11-03 | 11.35x |
| 2022-11-02 | 11.62x |
| 2022-11-01 | 11.45x |
| 2022-10-31 | 11.40x |
| 2022-10-28 | 11.16x |
| 2022-10-27 | 11.25x |
| 2022-10-26 | 11.35x |
| 2022-10-25 | 11.30x |
| 2022-10-24 | 11.01x |
| 2022-10-21 | 11.25x |
| 2022-10-20 | 10.97x |
| 2022-10-19 | 11.45x |
| 2022-10-18 | 11.38x |
| 2022-10-17 | 11.42x |
| 2022-10-14 | 10.73x |
| 2022-10-13 | 11.25x |
| 2022-10-12 | 10.82x |
| 2022-10-11 | 10.94x |
| 2022-10-10 | 11.13x |
| 2022-10-07 | 11.35x |
| 2022-10-06 | 11.42x |
| 2022-10-05 | 11.04x |
| 2022-10-04 | 10.97x |
| 2022-10-03 | 11.11x |
| 2022-09-30 | 12.10x |
| 2022-09-29 | 12.13x |
| 2022-09-28 | 12.42x |
| 2022-09-27 | 11.92x |
| 2022-09-26 | 11.39x |
| 2022-09-23 | 11.31x |
| 2022-09-22 | 12.30x |
| 2022-09-21 | 12.42x |
| 2022-09-20 | 12.42x |
| 2022-09-19 | 12.42x |
| 2022-09-16 | 11.60x |
| 2022-09-15 | 11.78x |
| 2022-09-14 | 12.24x |
| 2022-09-13 | 12.42x |
| 2022-09-12 | 13.27x |
| 2022-09-09 | 12.89x |
| 2022-09-08 | 12.83x |
| 2022-09-07 | 12.68x |
| 2022-09-06 | 12.86x |
| 2022-09-02 | 13.09x |
| 2022-09-01 | 13.30x |
| 2022-08-31 | 14.06x |
| 2022-08-30 | 14.06x |
| 2022-08-29 | 14.06x |
| 2022-08-26 | 14.44x |
| 2022-08-25 | 14.65x |
| 2022-08-24 | 14.38x |
| 2022-08-23 | 14.97x |
| 2022-08-22 | 15.44x |
| 2022-08-19 | 14.30x |
Showing the most recent 260 of 660 data points. The chart above shows the full history.
